# Paclitaxel-coated Balloons in Femoral Indication to Defeat Restenosis

> **NCT01083030** · PHASE3 · COMPLETED · sponsor: **University Hospital, Saarland** · enrollment: 90 (actual)

## Conditions studied

- Peripheral Artery Disease

## Interventions

- **DEVICE:** Percutaneous transluminal angioplasty (PTA)
- **COMBINATION_PRODUCT:** DCB

## Key facts

- **NCT ID:** NCT01083030
- **Lead sponsor:** University Hospital, Saarland
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2011-08
- **Final completion:** 2012-12
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2023-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01083030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01083030, "Paclitaxel-coated Balloons in Femoral Indication to Defeat Restenosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01083030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*